Winter Sebastian F, Klein Joshua P, Vaios Eugene J, Karschnia Philipp, Lee Eudocia Q, Shih Helen A, Loebel Franziska, Dietrich Jorg
From the Massachusetts General Hospital Cancer Center (S.F.W., E.J.V., P.K., J.D.) and Center for Neuro-Oncology, Dana-Farber Cancer Institute (E.Q.L.), Harvard Medical School; Division of Neuro-Oncology, Department of Neurology (S.F.W., E.J.V., P.K., J.D.), and Department of Radiation Oncology (H.A.S.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Neurosurgery (S.F.W., F.L.), Charité Universitatsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany; Departments of Neurology and Radiology (J.P.K.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Radiation Oncology (E.J.V.), Duke Cancer Institute, Durham, NC; and Department of Neurosurgery (P.K.), Ludwig Maximilians University, Munich, Germany.
Neurology. 2021 Jul 19;97(3):118-120. doi: 10.1212/WNL.0000000000012150.